- Home
- QTRX
QTRX
Quanterix Corporation
as 03-28-2025 4:00pm EST
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | BILLERICA |
| Market Cap: | N/A | IPO Year: | 2017 |
| Target Price: | $18.25 | AVG Volume (30 days): | 750.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.30 - $23.86 | Next Earning Date: | 03-17-2025 |
| Revenue: | $137,421,000 | Revenue Growth: | 12.30% |
| Revenue Growth (this year): | 16.41% | Revenue Growth (next year): | 18.00% |
Latest Quanterix Corporation News
QTRX Breaking Stock News: Dive into QTRX Ticker-Specific Updates for Smart Investing
PR Newswire
10 days ago
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN
Simply Wall St.
10 days ago
Quanterix Full Year 2024 Earnings: EPS Misses Expectations
Thomson Reuters StreetEvents
11 days ago
Q4 2024 Quanterix Corp Earnings Call
GuruFocus.com
11 days ago
Quanterix Corp (QTRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges
MT Newswires
12 days ago
Quanterix Q4 Net Loss Widens, Revenue Rises, 2025 Revenue Outlook Set
Business Wire
12 days ago
Quanterix Releases Financial Results for the Fourth Quarter of 2024
Business Wire
12 days ago
Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings Call
GlobeNewswire
12 days ago
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
Compare QTRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "QTRX Quanterix Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.